These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 25431023)

  • 21. Benefits of Permanent His Bundle Pacing Combined With Atrioventricular Node Ablation in Atrial Fibrillation Patients With Heart Failure With Both Preserved and Reduced Left Ventricular Ejection Fraction.
    Huang W; Su L; Wu S; Xu L; Xiao F; Zhou X; Ellenbogen KA
    J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28365568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Device Therapy for Rate Control: Pacing, Resynchronisation and AV Node Ablation.
    Lau DH; Thiyagarajah A; Willems S; Rostock T; Linz D; Stiles MK; Kaye D; Kalman JM; Sanders P
    Heart Lung Circ; 2017 Sep; 26(9):934-940. PubMed ID: 28687248
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atrioventricular junction ablation combined with either right ventricular pacing or cardiac resynchronization therapy for atrial fibrillation: the need for large-scale randomized trials.
    Bradley DJ; Shen WK
    Heart Rhythm; 2007 Feb; 4(2):224-32. PubMed ID: 17275763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of benefits and mortality in cardiac resynchronization therapy in patients with atrial fibrillation versus patients in sinus rhythm (Results of the Spanish Atrial Fibrillation and Resynchronization [SPARE] Study).
    Tolosana JM; Hernandez Madrid A; Brugada J; Sitges M; Garcia Bolao I; Fernandez Lozano I; Martinez Ferrer J; Quesada A; Macias A; Marin W; Escudier JM; Gomez AA; Gimenez Alcala M; Tamborero D; Berruezo A; Mont L;
    Am J Cardiol; 2008 Aug; 102(4):444-9. PubMed ID: 18678303
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atrioventricular Junction Ablation for Atrial Fibrillation.
    Patel D; Daoud EG
    Heart Fail Clin; 2016 Apr; 12(2):245-55. PubMed ID: 26968669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Feasibility and Efficacy of His Bundle Pacing or Left Bundle Pacing Combined With Atrioventricular Node Ablation in Patients With Persistent Atrial Fibrillation and Implantable Cardioverter-Defibrillator Therapy.
    Wang S; Wu S; Xu L; Xiao F; Whinnett ZI; Vijayaraman P; Su L; Huang W
    J Am Heart Assoc; 2019 Dec; 8(24):e014253. PubMed ID: 31830874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiac resynchronization therapy in patients with atrial fibrillation: a 2-year follow-up study.
    Eisen A; Nevzorov R; Goldenberg G; Kuznitz H; Porter A; Golovtziner G; Strasberg B; Haim M
    Pacing Clin Electrophysiol; 2013 Jul; 36(7):872-7. PubMed ID: 23594360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of rate-controlled persistent atrial fibrillation with clinical outcome and ventricular remodelling in recipients of cardiac resynchronization therapy.
    Wilton SB; Kavanagh KM; Aggarwal SG; Philippon F; Yee R; Cowan K; Exner DV
    Can J Cardiol; 2011; 27(6):787-93. PubMed ID: 21908159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of AV nodal ablation in cardiac resynchronization in patients with coexistent atrial fibrillation and heart failure a systematic review.
    Ganesan AN; Brooks AG; Roberts-Thomson KC; Lau DH; Kalman JM; Sanders P
    J Am Coll Cardiol; 2012 Feb; 59(8):719-26. PubMed ID: 22340263
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rhythm Control and AV Node Ablation in CRT Patients with Atrial Fibrillation: Should They be Performed Together or Alternatively?
    Ciszewski J; Sterlinski M
    Pacing Clin Electrophysiol; 2015 Jul; 38(7):906-7. PubMed ID: 25880466
    [No Abstract]   [Full Text] [Related]  

  • 31. Biventricular pacing improves cardiac function and prevents further left atrial remodeling in patients with symptomatic atrial fibrillation after atrioventricular node ablation.
    Orlov MV; Gardin JM; Slawsky M; Bess RL; Cohen G; Bailey W; Plumb V; Flathmann H; de Metz K
    Am Heart J; 2010 Feb; 159(2):264-70. PubMed ID: 20152225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complete atrioventricular block does not reduce long-term mortality in patients with permanent atrial fibrillation treated with cardiac resynchronization therapy.
    Tolosana JM; Trucco E; Khatib M; Doltra A; Borras R; Castel MÁ; Berruezo A; Arbelo E; Sitges M; Matas M; Guasch E; Brugada J; Mont L
    Eur J Heart Fail; 2013 Dec; 15(12):1412-8. PubMed ID: 23845796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Usefulness of echo-guided cardiac resynchronization pacing in patients undergoing "ablate and pace" therapy for permanent atrial fibrillation and effects of heart rate regularization and left ventricular resynchronization.
    Brignole M; Menozzi C; Botto GL; Mont L; Osca Asensi J; García Medina D; Oddone D; Navazio A; Luzi M; Iacopino S; De Fabrizio G; Proclemer A; Vardas P
    Am J Cardiol; 2008 Oct; 102(7):854-60. PubMed ID: 18805110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical Outcomes After Ablation of the AV Junction in Patients With Atrial Fibrillation: Impact of Cardiac Resynchronization Therapy.
    Mittal S; Musat DL; Hoskins MH; Prillinger JB; Roberts GJ; Nabutovsky Y; Merchant FM
    J Am Heart Assoc; 2017 Nov; 6(12):. PubMed ID: 29180458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiac resynchronization therapy in patients with permanent atrial fibrillation. Is it mandatory to ablate the atrioventricular junction to obtain a good response?
    Tolosana JM; Arnau AM; Madrid AH; Macias A; Lozano IF; Osca J; Quesada A; Toquero J; Francés RM; Bolao IG; Berruezo A; Sitges M; Alcalá MG; Brugada J; Mont L;
    Eur J Heart Fail; 2012 Jun; 14(6):635-41. PubMed ID: 22396459
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atrioventricular nodal ablation is an effective management strategy for atrial fibrillation in patients with hypertrophic cardiomyopathy.
    Butcher C; Rajappan S; Wharmby AL; Ullah W; Wong T; Jones D; Rajappan K; Martin C; Elliott P; Gill JS; Specterman M; Dhinoja MB; Sporton S; Lambiase PD; Hunter RJ; Honarbakhsh S
    Heart Rhythm; 2023 Dec; 20(12):1606-1614. PubMed ID: 37633429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Causes of non-response to cardiac resynchronization therapy in heart failure patients with permanent atrial fibrillation].
    Wang DM; Yu HB; Qi SY; Ding C; Wang G; Han YL; Zang HY; Ru LS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Sep; 40(9):757-61. PubMed ID: 23141088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term outcome of the atrioventricular node ablation and pacemaker implantation for symptomatic refractory atrial fibrillation.
    Tan ES; Rienstra M; Wiesfeld AC; Schoonderwoerd BA; Hobbel HH; Van Gelder IC
    Europace; 2008 Apr; 10(4):412-8. PubMed ID: 18272509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiac resynchronization therapy and atrial fibrillation.
    Kamath GS; Steinberg JS
    Cardiol J; 2009; 16(1):4-10. PubMed ID: 19130410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The importance of increased percentage of biventricular pacing to improve clinical outcomes in patients receiving cardiac resynchronization therapy.
    Gasparini M; Galimberti P; Ceriotti C
    Curr Opin Cardiol; 2013 Jan; 28(1):50-4. PubMed ID: 23196776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.